A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Urologic oncology
- Publicado em
- 31 out 2022
- Citações
- 11
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer
María T Melgarejo-Segura, Ana Morales Martínez, Yaiza Yáñez Castillo, Miguel Ángel Arrabal Polo, Pablo Gómez-Lechuga, Manuel Pareja-Vílchez, José Juan Jiménez-Moleón, Miguel Arrabal Martín
Descritores MeSH
- Non-Muscle Invasive Bladder Neoplasms
- Urinary Bladder Neoplasms
- Antibiotics, Antineoplastic
- BCG Vaccine
- Mitomycin
- Humans
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local
- Administration, Intravesical
Veja também
Estudos relacionados
- The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
- Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)
- Single dose perioperative intravesical instillation of gemcitabine versus mitomycin-C following resection of non-muscle invasive bladder cancer: A randomized controlled trial
- A randomized study comparing outcomes of intravesical Gemcitabine, Mitomycin C (as hyperthermic intravesical chemotherapy-HIVEC) and Bacillus-Calmette Guerin in intermediate and high-risk non-muscle invasive bladder cancer